It is essential to stress that these studies were based on cell lines derived from various tumor origins or with a different cellular context, which makes it difficult to draw conclusions about the impact of the p53 status on the growth inhibitory effect of Plk1 inhibition. This evidence concerns the gene PLK1 and neoplasm.